Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
32.6M
-
Shares change
-
-1.32K
-
Total reported value, excl. options
-
$294M
-
Value change
-
+$1.57M
-
Put/Call ratio
-
1.02
-
Number of buys
-
33
-
Number of sells
-
-37
-
Price
-
$9.04
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q1 2021
105 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q1 2021.
AVADEL PHARMACEUTICALS - COM (AVDL) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.6M shares
.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.74M shares), Avoro Capital Advisors LLC (4.37M shares), Vivo Capital, LLC (2.94M shares), BRANDES INVESTMENT PARTNERS, LP (2.93M shares), Polar Capital Holdings Plc (2.79M shares), COWEN AND COMPANY, LLC (2.5M shares), GENDELL JEFFREY L (1.93M shares), ACUTA CAPITAL PARTNERS, LLC (1.1M shares), RENAISSANCE TECHNOLOGIES LLC (929K shares), and Asymmetry Capital Management, L.P. (712K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.